companydirectorylist.com  Global Business Directory e directory aziendali
Ricerca Società , Società , Industria :


elenchi dei paesi
USA Azienda Directories
Canada Business Elenchi
Australia Directories
Francia Impresa di elenchi
Italy Azienda Elenchi
Spagna Azienda Directories
Svizzera affari Elenchi
Austria Società Elenchi
Belgio Directories
Hong Kong Azienda Elenchi
Cina Business Elenchi
Taiwan Società Elenchi
Emirati Arabi Uniti Società Elenchi


settore Cataloghi
USA Industria Directories














  • Johnson Johnson: Changing health for humanity
    We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal
  • Explore careers at Johnson Johnson | Johnson Johnson Careers
    Elevate your career with J J Discover global job opportunities to drive innovation, impact lives and grow in a supportive, mission-driven culture
  • Johnson Johnson Reports Q4 and Full-Year 2024 Results
    NEW BRUNSWICK, N J --(BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024 "2024 was a transformative year for Johnson Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson
  • Explore Johnson Johnson careers in the United States | Johnson . . .
    Be, feel and do your best The flexible employee benefits we offer at Johnson Johnson reflect Our Credo values and are a way to create a truly inclusive place where you belong When you’re at your best, and your family—however you define it—feels safe and well, nothing stands between you and your next breakthrough
  • Innovative Medicine - Johnson Johnson
    Patients inform and inspire our science-based innovations, which continue to change and save lives Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the medicines of tomorrow
  • Media Center - Johnson Johnson
    • 2025 First-Quarter reported sales growth of 2 4% to $21 9 Billion with operational growth of 4 2%* and adjusted operational growth of 3 3%* • 2025 First-Quarter earnings per share (EPS) increased to $4 54 which includes the reversal of special charges and adjusted EPS increased to $2 77 or 2 2%* • Significant new product pipeline progress including approval of TREMFYA in Crohn’s
  • Explore Johnson Johnson careers in India | Johnson Johnson Careers
    Discover exciting career opportunities at Johnson Johnson in India Search job openings and apply now to join a global leader in healthcare innovation
  • Contact us - Johnson Johnson
    Get in touch with Johnson Johnson Our Credo; Our Leadership; Code of Business Conduct; Corporate reports; Our culture of inclusion




Annuari commerciali , directory aziendali
Annuari commerciali , directory aziendali copyright ©2005-2012 
disclaimer